Satisfying the Hunger for a Prader-Willi Therapy

Anish Bhatnagar, CEO of Soleno Therapeutics, discusses Prader-Willi syndrome, the company’s therapy to treat the condition, and the significance of having a medicine that can address hyperphagia associated with the disorder.